0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Special Feature |

Picture of the Month—Diagnosis FREE

[+] Author Affiliations

Section Editor: Albert C. Yan, MD
Assistant Section Editor: Samir S. Shah, MD

More Author Information
Arch Pediatr Adolesc Med. 2006;160(2):190. doi:10.1001/archpedi.160.2.190.
Text Size: A A A
Published online

DENOUEMENT AND DISCUSSION: NEONATAL LUPUS ERYTHEMATOSUS

A 2-month-old, white, male infant had a 1-month history of a rash that began on the left face and spread to involve the scalp and right lower abdomen. According to his mother, the lesions appeared to be exacerbated by sun exposure. Prenatal and medical history were unremarkable. There was no family history of rheumatologic or autoimmune disease. Aside from the skin eruption noted, the results of the remainder of the physical examination were normal with no evidence of cardiac abnormalities or hepatosplenomegaly. A complete blood cell count with differential, liver enzyme profile, and a basic chemistry panel were all normal, and a skin fungal culture was negative. Antinuclear antibody (titer of 1:320) and anti-La/SSB antibody were both positive, but surprisingly, anti-Ro/SSA antibody was negative. Complete cardiac evaluation results were normal, including a normal electrocardiogram and echocardiogram. Although his mother was clinically asymptomatic, she also had a positive antinuclear antibody and anti-La/SSB antibody but negative anti-Ro/SSA antibody and negative double-stranded DNA. By 4 months of age, all of the cutaneous lesions had resolved spontaneously with aggressive sun protection, and no new clinical symptoms or physical findings were noted.

BACKGROUND

Neonatal lupus erythematosus was first described in a newborn in 1954 by McCuistion and Schoch,1 and it may occur as infrequently as 1 in 20 000 births.2 It is an uncommon, passively acquired autoimmune disease associated with the transplacental passage of maternal autoantibodies, in most cases anti-Ro/SSA and/or anti-La/SSB antibodies.2 These transplacentally acquired maternal autoantibodies are believed to cause cell injury leading to the development of clinical disease.2 Mothers of infants with neonatal lupus may have a known autoimmune disease such as lupus erythematosus, Sjögren syndrome, or mixed connective tissue disease; however, a sizable proportion of mothers can also be clinically asymptomatic. Owing to the subtle and varied clinical presentation of neonatal lupus, a diagnosis can be difficult to make.

CLINICAL FEATURES AND MANAGEMENT

The clinical features of neonatal lupus can include cutaneous, cardiac, hepatic, and hematologic abnormalities. The skin eruption may be present at birth or can present during the first several weeks of life, most commonly on the head and neck, with frequent accentuation in the periorbital distribution.3,4 Classically, the cutaneous lesions are annular erythematous plaques with scale that may be exacerbated by sun exposure.3,4 The rash is often misdiagnosed as tinea corporis or atopic dermatitis.4 The lesions usually resolve spontaneously over several months, but they occasionally may leave residual atrophy or telangiectasia. The most severe and life-threatening clinical manifestation of neonatal lupus is third-degree congenital heart block, which can be detected in utero during the second or third trimester.2 Hepatobiliary and hematologic involvement may be asymptomatic and detected only through laboratory evaluation during the first several months of life.5,6 Rarely, severe liver failure may occur in the neonatal period.7 Although neurologic abnormalities are not a clinical feature of neonatal lupus, transient asymptomatic brain abnormalities have been detected on computed tomographic scan in several infants with neonatal lupus.8

Infants and their mothers will usually have positive anti-Ro/SSA antibodies, will less commonly have positive anti-La/SSB antibodies, and will rarely have a positive anti-U1RNP antibody.2,6 Other laboratory abnormalities detected during infancy can include anemia, thrombocytopenia, neutropenia, and elevation of hepatic transaminases, γ-glutamyltransferase, or conjugated bilirubin.57

All infants with suspected neonatal lupus should receive laboratory screening for the presence of autoantibodies and hematologic or hepatic involvement as well a thorough cardiac evaluation. Neonates with congenital heart block may require pacemaker implantation. Except for those infants with congenital heart block, clinical symptoms are usually transient and resolve by age 6 to 9 months.4,5 Often, only aggressive broad-spectrum (UV-A and UV-B) photoprotection and clinical and laboratory monitoring are required during infancy.2 Infants and children do not appear to be at an increased risk of developing autoimmune disease as a direct result of their history of neonatal lupus; however, they should be followed up closely throughout childhood and adolescence since their overall risk of rheumatologic disease may be increased relative to the general population because of their familial predisposition.9 Asymptomatic mothers of infants with neonatal lupus are at risk of developing rheumatologic disease in the future, and any subsequent pregnancy should be monitored closely.46

Correspondence: Kimberly A. Horii, MD, Section of Dermatology, Children's Mercy Hospital, 2401 Gillham Rd, Kansas City, MO 64108 (kahorii@cmh.edu).

Accepted for Publication: August 1, 2005.

McCuistion  CHSchoch  EP  Jr Possible discoid lupus erythematosus in newborn infant AMA Arch Derm Syphilol 1954;70782- 785
PubMed Link to Article
Lee  LA Neonatal lupus erythematosus J Investig Dermatol Symp Proc 2004;952- 56
PubMed Link to Article
Weston  WLMorelli  JGLee  LA The clinical spectrum of anti-Ro-positive cutaneous neonatal lupus erythematosus J Am Acad Dermatol 1999;40675- 681
PubMed Link to Article
Neiman  ARLee  LAWeston  WLBuyon  JP Cutaneous manifestations of neonatal lupus without heart block J Pediatr 2000;137674- 680
PubMed Link to Article
Cimaz  RSpence  DLHornberger  LSilverman  ED Incidence and spectrum of neonatal lupus erythematosus J Pediatr 2003;142678- 683
PubMed Link to Article
Lee  LA Neonatal lupus Paediatr Drugs 2004;671- 78
PubMed Link to Article
Lee  LASokol  RJBuyon  JP Hepatobiliary disease in neonatal lupus Pediatrics 2002;109e11
PubMed Link to Article
Prendiville  JSCabral  DAPoskitt  KJAu  SSargent  MA Central nervous system involvement in neonatal lupus erythematosus Pediatr Dermatol 2003;2060- 67
PubMed Link to Article
Martin  VLee  LAAskanase  ADKatholi  MBuyon  JP Long-term followup of children with neonatal lupus and their unaffected siblings Arthritis Rheum 2002;462377- 2383
PubMed Link to Article

Figures

Tables

References

McCuistion  CHSchoch  EP  Jr Possible discoid lupus erythematosus in newborn infant AMA Arch Derm Syphilol 1954;70782- 785
PubMed Link to Article
Lee  LA Neonatal lupus erythematosus J Investig Dermatol Symp Proc 2004;952- 56
PubMed Link to Article
Weston  WLMorelli  JGLee  LA The clinical spectrum of anti-Ro-positive cutaneous neonatal lupus erythematosus J Am Acad Dermatol 1999;40675- 681
PubMed Link to Article
Neiman  ARLee  LAWeston  WLBuyon  JP Cutaneous manifestations of neonatal lupus without heart block J Pediatr 2000;137674- 680
PubMed Link to Article
Cimaz  RSpence  DLHornberger  LSilverman  ED Incidence and spectrum of neonatal lupus erythematosus J Pediatr 2003;142678- 683
PubMed Link to Article
Lee  LA Neonatal lupus Paediatr Drugs 2004;671- 78
PubMed Link to Article
Lee  LASokol  RJBuyon  JP Hepatobiliary disease in neonatal lupus Pediatrics 2002;109e11
PubMed Link to Article
Prendiville  JSCabral  DAPoskitt  KJAu  SSargent  MA Central nervous system involvement in neonatal lupus erythematosus Pediatr Dermatol 2003;2060- 67
PubMed Link to Article
Martin  VLee  LAAskanase  ADKatholi  MBuyon  JP Long-term followup of children with neonatal lupus and their unaffected siblings Arthritis Rheum 2002;462377- 2383
PubMed Link to Article

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Collections
PubMed Articles